LYAR Antikörper
-
- Target Alle LYAR Antikörper anzeigen
- LYAR (Ly1 Antibody Reactive (LYAR))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LYAR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purified
- Immunogen
- LYAR antibody was raised using a synthetic peptide corresponding to a region with amino acids EQQGEVKKNKRERKEERQKKRKREKKELKLENHQENSRNQKPKKRKKGQE
- Top Product
- Discover our top product LYAR Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
LYAR Blocking Peptide, catalog no. 33R-2674, is also available for use as a blocking control in assays to test for specificity of this LYAR antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LYAR antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- LYAR (Ly1 Antibody Reactive (LYAR))
- Andere Bezeichnung
- LYAR (LYAR Produkte)
- Synonyme
- ZC2HC2 antikoerper, ZLYAR antikoerper, MLZ-264 antikoerper, Ly1 antibody reactive antikoerper, Ly1 antibody reactive clone antikoerper, LYAR antikoerper, Lyar antikoerper
- Substanzklasse
- Antibody
- Hintergrund
- LYAR contains a zinc finger motif and three copies of nuclear localization signals. LYAR is mainly localized to the nucleoli. LYAR is present at high levels in early embryos and preferentially in the liver fetal thymus.
- Molekulargewicht
- 44 kDa (MW of target protein)
-